Clinical Trial Update: Cholecalciferol Comedication in IBD - the 5C-study [Phase 3]

View source ↗

Summary

Phase 3 trial (5C-study) evaluating cholecalciferol as a comedication in inflammatory bowel disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Inflammatory Bowel Diseases | Phase 3 | Status: COMPLETED